Source comparison
Comparison Table: MOTS-c vs SS-31 Key Differentiators
Origin Mitochondrial-encoded peptide (endogenous) Synthetic peptide Primary Mechanism Activates AMPK, systemic metabolic regulation Binds cardiolipin, protects inner mitochondrial membrane, reduces ROS Main Targets Skeletal muscle, liver, adipose tissue (metab
This comparison does not assign a generated winner or score.
- Origin
- Mitochondrial-encoded peptide (endogenous)
- Synthetic peptide
- Primary Mechanism
- Activates AMPK, systemic metabolic regulation
- Binds cardiolipin, protects inner mitochondrial membrane, reduces ROS
- Main Targets
- Skeletal muscle, liver, adipose tissue (metabolic pathways)
- Inner mitochondrial membrane, oxidative stress, specific organs (heart, kidney, brain)
- Key Research Areas
- Metabolic health, insulin sensitivity, obesity, exercise mimicry, longevity
- Organ protection (cardiac, renal, neural), ischemia-reperfusion injury, mitochondrial diseases
- Cellular Impact
- Systemic metabolic modulation, gene expression
- Direct mitochondrial integrity and function, oxidative stress mitigation
- Discovery Year (Approx.)
- 2015
- Early 2000s
- This table succinctly highlights why the MOTS-c vs SS-31 discussion isn't about superiority but specificity. Each has its distinct place in the toolkit of a forward-thinking researcher.